2024-11-28 - Analysis Report
## Eli Lilly and Co. (LLY) Stock Analysis Report

**1. Performance Relative to S&P 500 (VOO):**

Eli Lilly and Co. (LLY) is a pharmaceutical company that discovers, develops, manufactures, and markets pharmaceutical products.  The cumulative return of LLY is 624.48%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 128.86%. The difference is 495.6%, placing it at the 73.7th percentile of its historical range relative to the S&P 500.  The provided data shows consistently high alpha values, indicating outperformance relative to the market benchmark.


**2. Recent Price Movement:**

* **Closing Price:** $788.19 (Last Market: $788.61)
* **5-Day Moving Average:** $766.09
* **20-Day Moving Average:** $784.39
* **60-Day Moving Average:** $865.17

The price is currently below its 20-day and 60-day moving averages, suggesting a potential short-term downward trend.  The recent price is slightly below the last market price, indicating minimal change.

**3. Technical Indicators and Expected Return:**

* **RSI:** 48.13 (Slightly below neutral; neither overbought nor oversold)
* **PPO:** 0.47 (Positive, indicating bullish momentum)
* **Delta_Previous_Relative_Divergence:** -9.0% (Short-term bearish divergence)
* **Expected Return:** 578.1% (This is a projected long-term (2+ years) excess return compared to the S&P 500 if a buy-and-hold strategy is employed.  This figure needs further validation considering market fluctuations and underlying assumptions.)

The current price of $788.61 does not suggest a significant immediate price jump or drop, although the negative divergence suggests caution regarding further price increases in the immediate future.

**4. Recent Financial Performance and Outlook:**

The provided financial data shows fluctuating EPS and revenue.  While recent quarters show high revenue and profit margins, there's considerable variation. The October 30th, 2024 earnings report is notably lower than the August report and needs further analysis to assess if it meets or exceeds expectations.  More detailed information on analyst expectations would provide a clearer picture.

**5.  Financial Information Analysis:**

The high revenue and profitability (80+% profit margins) are positive signs. However, the ROE fluctuates significantly, indicating potential volatility in profitability.  Further analysis is needed to understand the factors driving these fluctuations (e.g., one-time gains or losses).


**6. News and Recent Issues:**

*(This section requires information from sources like Shacknews, FINBOLD, and other financial news outlets within the last two days.  Please provide the news articles for a complete analysis.)*  A review of recent news, including earnings calls and analyst reports, is critical to understanding the market outlook and recent performance highlights. This will supplement the analysis with current market sentiment.


**7. Overall Summary:**

LLY has shown significant outperformance compared to the S&P 500 in the long term. However, recent price action and technical indicators suggest a potential short-term bearish trend. The company's financial performance reveals high revenue and profitability, although the ROE shows some variability.  A review of recent news and analyst opinions is crucial to fully assess the current market outlook and potential future performance.  The high expected return is a positive indicator for long-term investors, but it relies on sustained growth and market conditions, warranting caution.  Thorough due diligence, including reviewing recent earnings calls and considering the risk profile, is recommended before making any investment decisions.


**8. Disclaimer:** This report is for informational purposes only and does not constitute investment advice.  The analysis relies on the limited data provided and may not capture all relevant factors influencing LLY's stock price.  Conduct thorough research and consult with a qualified financial advisor before making any investment decisions.
